Stocks

Why Gildan Activewear Inc. stock is sliding today

By Wealth Awesome Newsroom -
Stocks & ETFs:GIL.TO
Photos provided by Pexels

Gildan Activewear Inc. is facing a notable decline as investor confidence wanes amidst troubling allegations.

Gildan Activewear Inc. (GIL.TO) saw its stock slide by 2.33% in the latest trading session, closing at CA$73.23. This downturn follows a tumultuous week marked by serious allegations regarding the company’s revenue reporting practices, which have cast a shadow over its recent performance.

Investor takeaway: Investors should approach Gildan with caution as the company navigates serious allegations and a potential class-action investigation, which could impact its stock performance in the near term.

Advertisement

Qtrade Direct Investing

Get up to $2,000 cash back

Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.

Gildan Activewear Inc.

GIL.TO

Full stock page →

GIL.TO

Gildan Activewear Inc.

Source:WealthAwesomeWealthAwesome
$13.29 (-15.17%)
120 day period
$70.39$84.69$99.00Jan 20Apr 16Jul 10

Market cap

$13.76B

P/E

30.6x

52W high

$99.56

52W low

$62.34

1W change

+2.24%

Beta

1.12

Analyst Price Targets

Based on analyst covering GIL

📈

Wall Street analysts forecast GIL stock price to rise 43.6% over the next 12 months.

Consensus

No Rating

Avg. Target

C$106.77

+43.6% Upside

Current Price

C$74.33

Last close

Analyst ratings and price targets are updated periodically. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on GIL's historical volatility

HistoricalForecast68%95%
C$28.48C$55.52C$82.56C$109.60C$136.64C$163.68TodayMar 4May 7Jul 10Aug 22Oct 5Nov 17

30-Day Vol

70.6%

Annualized

90-Day Vol

52.9%

Annualized

Trend (90d)

-23.7%

Annualized drift

90d Mean

C$68.30

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$72.26C$56.63C$92.21
60 trading daysC$70.26C$49.77C$99.17
90 trading daysC$68.30C$44.78C$104.18

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

Gildan's Market Cap Drops to CA$13.03 Billion

The recent decline has significantly reduced Gildan's market cap, reflecting investor concerns and market volatility surrounding the company.

Bull case

If Gildan can effectively address the allegations and restore investor confidence, its solid fundamentals and growth potential could set the stage for a recovery.

Bear case

Ongoing scrutiny from investors and possible legal challenges may lead to further drops in stock value, especially if the allegations are proven true.

The Impact of Allegations on Stock Performance

The recent allegations against Gildan regarding inflated revenue through channel stuffing have shaken investor confidence. This comes after a brief period of optimism when the stock had surged by 5.5%. The market's reaction shows a cautious sentiment as investors consider how these allegations might affect Gildan's financial health.

Market Reactions and Analyst Opinions

Following the short report that triggered the stock's decline, analysts have taken a neutral stance, with firms like RBC and CIBC keeping their outlooks unchanged. However, the lack of adjustments in earnings estimates suggests that investor sentiment may remain lukewarm until there’s more clarity. The consensus EPS estimate for Gildan has stayed the same, indicating uncertainty about future performance.

What Lies Ahead for Gildan?

As Gildan navigates these turbulent waters, the company’s ability to address the allegations and reassure investors will be crucial. The upcoming quarterly earnings report will be key in determining whether the stock can rebound or if further declines are on the horizon. Investors should keep a close watch on developments, especially any updates from the ongoing investigation.

Advertisement

Sponsored links

Advertisement